Literature DB >> 8449078

Empyema of the thorax in adults. Etiology, microbiologic findings, and management.

I Alfageme1, F Muñoz, N Peña, S Umbría.   

Abstract

The etiology, microbiologic findings, and management of 82 episodes of empyema treated by our unit over a period of 6 years were analyzed. Average patient age was 54 years. Eighty-two percent had underlying disease such as alcoholism (29 percent), malignancy (23 percent), and diabetes mellitus (20 percent). Sixty (73 percent) had an empyema develop secondary to a bronchopulmonary infection. Other etiologies were as follows: infradiaphragmatic sepsis, five cases; iatrogenic, ten cases; and idiopathic, seven cases. Cultures were positive in 76 cases and negative in the remaining 6 (2 positive Gram stains, 1 positive under bacilloscopy, and 3 were sterile). Anaerobes were isolated from 25 and aerobes from 47 of the positive cultures. A single bacteria was isolated from 43 and multiple organisms (average: 2.63/case) grew on the remaining 33 positive cultures. Length of hospitalization averaged 37 days. Seven patients received antibiotics only, thoracentesis was performed on three, intercostal chest tube drainage was required in 72, and more aggressive surgery was performed on 12 patients (7 with fibrothorax and 5 with pneumonectomy). Streptokinase was instilled into the pleural space of eight patients with good results. Pleural drainage superinfection occurred at a rate of 8.5 percent. Nine patients died; the remaining recovered. Only three deaths came about as a direct result of the empyema.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8449078     DOI: 10.1378/chest.103.3.839

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  28 in total

1.  A new sterilization technique with balloon-tube thoracostomy for thoracic empyema.

Authors:  Chikabumi Kadoyama; Aki Ishikawa; Mitsutoshi Shiba; Kazuhiro Yasufuku; Hidehisa Hoshino; Toshikazu Suwa; Takehiko Fujisawa
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2003-09

2.  BTS guidelines for the management of pleural infection.

Authors:  C W H Davies; F V Gleeson; R J O Davies
Journal:  Thorax       Date:  2003-05       Impact factor: 9.139

3.  68-year-old man with chronic cough and weight loss.

Authors:  Megan M Dulohery; Furman S McDonald
Journal:  Mayo Clin Proc       Date:  2010-06       Impact factor: 7.616

4.  Involvement of Heparanase in Empyema: Implication for Novel Therapeutic Approaches.

Authors:  Moshe Lapidot; Uri Barash; Yaniv Zohar; Yuval Geffen; Inna Naroditsky; Neta Ilan; Lael Anson Best; Israel Vlodavsky
Journal:  J Clin Cell Immunol       Date:  2015-02

5.  Randomised controlled trial of intrapleural streptokinase in community acquired pleural infection.

Authors:  R J Davies; Z C Traill; F V Gleeson
Journal:  Thorax       Date:  1997-05       Impact factor: 9.139

6.  Risk of developing pleural empyema in patients with stroke: a propensity-matched cohort study.

Authors:  Te-Chun Shen; Chi-Yu Lin; Cheng-Li Lin; Chia-Hung Chen; Chih-Yen Tu; Te-Chun Hsia; Chuen-Ming Shih; Wu-Huei Hsu; Fung-Chang Sung
Journal:  Intern Emerg Med       Date:  2017-07-11       Impact factor: 3.397

Review 7.  Pneumonia and empyema: causal, casual or unknown.

Authors:  Lindsay McCauley; Nathan Dean
Journal:  J Thorac Dis       Date:  2015-06       Impact factor: 2.895

8.  Pleural Empyema Following Liver Resection: A Rare But Serious Complication.

Authors:  Claire Goumard; David Fuks; François Cauchy; Jacques Belghiti; Catherine Paugam-Burtz; Yves Castier; Olivier Soubrane
Journal:  World J Surg       Date:  2016-12       Impact factor: 3.352

9.  Thoracoscopic management of empyema thoracis.

Authors:  Michael A Wait; Daniel L Beckles; Michelle Paul; Margaret Hotze; Michael J Dimaio
Journal:  J Minim Access Surg       Date:  2007-10       Impact factor: 1.407

10.  Pneumonia recovery: discrepancies in perspectives of the radiologist, physician and patient.

Authors:  Anke H W Bruns; Jan Jelrik Oosterheert; Rachida El Moussaoui; Brent C Opmeer; Andy I M Hoepelman; Jan M Prins
Journal:  J Gen Intern Med       Date:  2009-12-05       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.